PolyPid Ltd. operates as a phase 3 biopharma company. The firm focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
How did PYPD's recent EPS compare to expectations?
The most recent EPS for PolyPid Ltd is $, expectations of $.
How did PolyPid Ltd PYPD's revenue perform in the last quarter?
PolyPid Ltd revenue for the last quarter is $
What is the revenue estimate for PolyPid Ltd?
According to of Wall street analyst, the revenue estimate of PolyPid Ltd range from $ to $
What's the earning quality score for PolyPid Ltd?
PolyPid Ltd has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does PolyPid Ltd report earnings?
PolyPid Ltd next earnings report is expected in
What are PolyPid Ltd's expected earnings?
PolyPid Ltd expected earnings is $, according to wall-street analysts.